Beike Biotechnology’s Shenzhen Facility Earns AABB Accreditation

Beike Biotechnology’s Shenzhen Facility Earns AABB Accreditation

Shenzhen, China – Beike Biotechnology has been granted AABB accreditation for cord blood processing, storage, distribution, cell therapy activity (MSC, cord blood; MSC, placenta; NC, whole blood), somatic cell processing,…

A Tale of Two Spinal Cord Injury Patients

Shenzhen, China –- June 16th, 2006 — Shenzhen Beike Biotechnology Co., Ltd has announced the successful treatment of two spinal cord injury patients with different methods for treatment – one…

Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease

Beike Biotechnology Co., Ltd. today announced that a team led by Dr. Yang Xiaofeng at its collaborating hospital in Shenyang completed a study to assess clinical efficacy, safety, and feasibility…

American Toddler Sees Dramatic Improvement from Beike Biotechnology Stem Cell Treatment

SHENZHEN, China, Aug. 14 /PRNewswire-USNewswire/ — Shenzhen Beike Biotechnology Co., Ltd. (http://www.beikebiotech.com) today announced the successful treatment with umbilical cord stem cells of three-and-a-half-year- old American toddler Lukas Nguyen. At…

Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.

SHENZHEN, China, Nov. 4 /PRNewswire-Asia/ — Shenzhen Beike Biotechnology Co. Ltd. (http://www.beikebiotech.com ), China’s leading stem cell research and regenerative medicine company, announced that it has entered into an agreement…

Stem Cell Leader Beike Biotech and China’s Tsinghua University Receive USD $4 Million for Stem Cell

Patients suffering from a range of debilitating illnesses, such as spinal cord injury, cerebral palsy, optic nerve hypoplasia, multiple sclerosis and ataxia stand to benefit from a new laboratory, established…


1 2 8 9